Results 271 to 280 of about 31,066,857 (388)

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Molecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte, Osheen Sharma, Laura Leuenberger, Emelie Wallin, Josefin Fernebro, Päivi Östling, Rebecka Bergström, Johan Lindberg, Ulrika Joneborg, Olli Kallioniemi, Brinton Seashore‐Ludlow   +10 more
wiley   +1 more source

A Case of Infraorbital B-cell Lymphoma Masquerading as an Abscess. [PDF]

Cancer Diagn Progn
Rashid S, Sandozi M, Pamulapati S, Doniparthi A, Pocha S, Khan MA.   +5 more
europepmc   +1 more source

Mechanisms of B Cell Tolerance [PDF]

, 1977
Richard B. Bankert, George L. Mayers, David Pressman   +2 more
openalex   +1 more source

Germinal Center B Cell Dynamics.

Immunity, 2016
L. Mesin, Jonatan Ersching, G. Victora
semanticscholar   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

Tumor progression locus 2, a new potential prognostic factor and therapeutic target in activated B-cell-like diffuse large B-cell lymphoma. [PDF]

Blood Cancer J
Yoshifuji K, Motomura Y, Saito M, Kawade G, Watabe S, Yamamoto K, Soejima M, Nogami A, Aoyama S, Mori T, Nagao T.   +10 more
europepmc   +1 more source

Altered B cell signalling in autoimmunity

Nature reviews. Immunology, 2017
D. Rawlings, Genita Metzler, Michelle N Wray-Dutra, Shaun W. Jackson   +3 more
semanticscholar   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Outcomes of the transformation to diffuse large B-cell lymphoma in hodgkin lymphoma and indolent B-cell non-Hodgkin lymphoma: a population-based study. [PDF]

Ann Hematol
Zheng W, Peng B, Chen H, Wang S, Guan L, Gao X.   +5 more
europepmc   +1 more source

Regional T- and B-cell responses in influenza-infected ferrets [PDF]

, 1978
C. McLaren, G M Butchko
openalex   +1 more source